Literature DB >> 21232699

Real-time 3D echo in patient selection for cardiac resynchronization therapy.

Stamatis Kapetanakis1, Amit Bhan, Francis Murgatroyd, Mark T Kearney, Nicholas Gall, Qing Zhang, Cheuk-Man Yu, Mark J Monaghan.   

Abstract

OBJECTIVES: this study investigated the use of 3-dimensional (3D) echo in quantifying left ventricular mechanical dyssynchrony (LVMD), its interhospital agreement, and potential impact on patient selection.
BACKGROUND: assessment of LVMD has been proposed as an improvement on conventional criteria in selecting patients for cardiac resynchronization therapy (CRT). Three-dimensional echo offers a reproducible assessment of left ventricular (LV) structure, function, and LVMD and may be useful in selecting patients for this intervention.
METHODS: we studied 187 patients at 2 institutions. Three-dimensional data from baseline and longest follow-up were quantified for volume, left ventricular ejection fraction (LVEF), and systolic dyssynchrony index (SDI). New York Heart Association (NYHA) functional class was assessed independently. Several outcomes from CRT were considered: 1) reduction in NYHA functional class; 2) 20% relative increase in LVEF; and 3) 15% reduction in LV end-systolic volume. Sixty-two cases were shared between institutions to analyze interhospital agreement.
RESULTS: there was excellent interhospital agreement for 3D-derived LV end-diastolic and end- systolic volumes, EF, and SDI (variability: 2.9%, 1%, 7.1%, and 7.6%, respectively). Reduction in NYHA functional class was found in 78.9% of patients. Relative improvement in LVEF of 20% was found in 68% of patients, but significant reduction in LV end-systolic volume was found in only 41.5%. The QRS duration was not predictive of any of the measures of outcome (area under the curve [AUC]: 0.52, 0.58, and 0.57 for NYHA functional class, LVEF, and LV end-systolic volume), whereas SDI was highly predictive of improvement in these parameters (AUC: 0.79, 0.86, and 0.66, respectively). For patients not fulfilling traditional selection criteria (atrial fibrillation, QRS duration <120 ms, or undergoing device upgrade), SDI had similar predictive value. A cutoff of 10.4% for SDI was found to have the highest accuracy for predicting improvement following CRT.
CONCLUSIONS: the LVMD quantification by 3D echo is reproducible between centers. SDI was an excellent predictor of response to CRT in this selected patient cohort and may be valuable in identifying a target population for CRT irrespective of QRS morphology and duration. 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21232699     DOI: 10.1016/j.jcmg.2010.09.021

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  13 in total

1.  Quantitative analysis of left ventricular dyssynchrony using cardiac computed tomography versus three-dimensional echocardiography.

Authors:  Sebastian J Buss; Felix Schulz; David Wolf; Waldemar Hosch; Christian Galuschky; Georg Schummers; Evangelos Giannitsis; Hans-Ulrich Kauczor; Christian Zugck; Ruediger Becker; Stefan E Hardt; Hugo A Katus; Grigorios Korosoglou
Journal:  Eur Radiol       Date:  2012-01-22       Impact factor: 5.315

Review 2.  Current role of echocardiography in cardiac resynchronization therapy.

Authors:  Donato Mele; Matteo Bertini; Michele Malagù; Marianna Nardozza; Roberto Ferrari
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

Review 3.  Three-Dimensional Echocardiography: Current Status and Real-Life Applications.

Authors:  Victor Chien-Chia Wu; Masaaki Takeuchi
Journal:  Acta Cardiol Sin       Date:  2017-03       Impact factor: 2.672

4.  The potential role of gated myocardial perfusion SPECT imaging in patient selection for cardiac resynchronization therapy.

Authors:  Nina Ajmone Marsan; Jeroen J Bax
Journal:  J Nucl Cardiol       Date:  2014-08-12       Impact factor: 5.952

Review 5.  Reverse remodelling and myocardial recovery in heart failure.

Authors:  Gene H Kim; Nir Uriel; Daniel Burkhoff
Journal:  Nat Rev Cardiol       Date:  2017-09-21       Impact factor: 32.419

6.  Current clinical applications of transthoracic three-dimensional echocardiography.

Authors:  Luigi P Badano; Francesca Boccalini; Denisa Muraru; Lucia Dal Bianco; Diletta Peluso; Roberto Bellu; Giacomo Zoppellaro; Sabino Iliceto
Journal:  J Cardiovasc Ultrasound       Date:  2012-03-27

7.  Sources of variation and bias in assessing left ventricular volumes and dyssynchrony using three-dimensional echocardiography.

Authors:  Denisa Muraru; Luigi P Badano; Davide Ermacora; Gianluca Piccoli; Sabino Iliceto
Journal:  Int J Cardiovasc Imaging       Date:  2011-11-27       Impact factor: 2.357

Review 8.  Cardiac Resynchronization Therapy in Non-Ischemic Cardiomyopathy.

Authors:  Miriam Shanks; Victoria Delgado; Jeroen J Bax
Journal:  J Atr Fibrillation       Date:  2016-02-29

9.  Acute beneficial hemodynamic effects of a novel 3D-echocardiographic optimization protocol in cardiac resynchronization therapy.

Authors:  Carolin Sonne; Lorenz Bott-Flügel; Simon Hauck; Hasema Lesevic; Petra Barthel; Fabian Michalk; Katharina Hoppe; Jörg Hausleiter; Albert Schömig; Christof Kolb
Journal:  PLoS One       Date:  2012-02-03       Impact factor: 3.240

10.  Clinical implication of mechanical dyssynchrony in heart failure.

Authors:  Qing Zhang; Cheuk-Man Yu
Journal:  J Cardiovasc Ultrasound       Date:  2012-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.